Skip to content
2000
Volume 32, Issue 10
  • ISSN: 0929-8665
  • E-ISSN: 1875-5305

Abstract

Introduction

The shepherin II peptide is characterized by a histidine/glycine-rich sequence. This study aimed to design, express recombinantly, and evaluate the antiviral activity of shepherin II against hepatitis A virus (HAV).

Methods

The shepherin II gene was reverse-translated, cloned into the pET-3a vector, and expressed in BL21 (DE3) pLysS cells induced with 2 mM IPTG. Purification was achieved cation exchange chromatography, and intact mass analysis using mass spectrometry was carried out. Cytotoxicity on normal Vero cells and antiviral activity on HAV were evaluated.

Results

The mass spectrometry confirmed a primary peptide fragment with a molecular weight of 3,421.30 Da (100% relative abundance). SDS-PAGE verified peptide expression. Cytotoxicity tests on Vero cells showed a CC of 219.26 ± 7.91 µg/ml. Antiviral assay revealed an EC of 113.92 ± 4.58 µg/ml against HAV, resulting in a selectivity index (SI) of 1.92. This SI indicates limited selectivity compared to the reference drug amantadine, which exhibited an EC of 5.67 ± 0.71 µg/ml and an SI of 53.41.

Discussion

The recombinant expression of shepherin II was successfully achieved and confirmed by mass spectrometry and SDS-PAGE. The peptide showed measurable antiviral activity against HAV.

Conclusion

This study demonstrated the feasibility of recombinant shepherin II production and assessed its antiviral activity. However, the limited selectivity index of shepherin II remains a challenge that needs to be addressed through molecular modification or alternative delivery strategies to improve its clinical potential.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ppl/10.2174/0109298665413796251002111415
2025-10-23
2026-03-04

  • From This Site

    /content/journals/ppl/10.2174/0109298665413796251002111415
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MaX. AminovR. FrancoO.L. de la Fuente-NunezC. WangG. WangJ. Editorial: Antimicrobial peptides and their druggability, bio-safety, stability, and resistance.Front. Microbiol.202415142595210.3389/fmicb.2024.1425952 38846567
     [Google Scholar]
  2. OkashaH. SamirS. NasrS.M. Purified recombinant human Chromogranin A N46 peptide with remarkable anticancer effect on human colon cancer cells.Bioorg. Chem.2021115June10526610.1016/j.bioorg.2021.105266 34449322
     [Google Scholar]
  3. FontanotA. EllingerI. UngerW.W.J. HaysJ.P. A comprehensive review of recent research into the effects of antimicrobial peptides on biofilms—january 2020 to september 2023.Antibiotics202413434310.3390/antibiotics13040343 38667019
     [Google Scholar]
  4. XuL. ShaoC. LiG. ShanA. ChouS. WangJ. MaQ. DongN. Conversion of broad-spectrum antimicrobial peptides into species-specific antimicrobials capable of precisely targeting pathogenic bacteria.Sci. Rep.202010194410.1038/s41598‑020‑58014‑6 31969663
     [Google Scholar]
  5. OkashaH. NasrS.M. SamirS. Recombinant expression of Cec-B peptide in Escherichia coli with a significant anticancer effect on hepatocellular carcinoma.Curr. Pharm. Biotechnol.20212291235124510.2174/1389201022666210104121709 33397234
     [Google Scholar]
  6. ParkC.J. ParkC.B. HongS.S. LeeH.S. LeeS.Y. KimS.C. Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd’s purse, Capsella bursa-pastoris.Plant Mol. Biol.200044218719710.1023/A:1006431320677 11117262
     [Google Scholar]
  7. LeiJ. SunL. HuangS. ZhuC. LiP. HeJ. MackeyV. CoyD.H. HeQ. The antimicrobial peptides and their potential clinical applications.Am. J. Transl. Res.201911739193931 31396309
     [Google Scholar]
  8. NasrS.M. SamirS. OkashaH. Interdisciplinary gene manipulation, molecular cloning, and recombinant expression of modified human growth hormone isoform-1 in E. coli system.Int. J. Biol. Macromol.2024257Pt 112863710.1016/j.ijbiomac.2023.128637 38061513
     [Google Scholar]
  9. El-DabaaE. OkashaH. SamirS. NasrS.M. El-KalamawyH.A. SaberM.A. Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity.Arab. J. Chem.202215510379910.1016/j.arabjc.2022.103799
     [Google Scholar]
  10. MohamedO.A. SamirS. OmarH. HassanE.A. AbdelazeemE. Lab-scale preparation of recombinant human insulin-like growth factor-1 in Escherichia coli and its potential safety on normal human lung cell line.Recent Pat. Biotechnol.202216326628010.2174/1872208316666220412105822 35418294
     [Google Scholar]
  11. WangG. The antimicrobial peptide database is 20 years old: Recent developments and future directions.Protein Sci.20233210e477810.1002/pro.4778 37695921
     [Google Scholar]
  12. WangG. VaismanI.I. van HoekM.L. Machine learning prediction of antimicrobial peptides.Methods Mol. Biol.2022240513710.1007/978‑1‑0716‑1855‑4_1 35298806
     [Google Scholar]
  13. WangG. Unifying the classification of antimicrobial peptides in the antimicrobial peptide database.Methods Enzymol.202266340211810.1016/j.ymeth.2022.03.009 35168785
     [Google Scholar]
  14. WangG. LiX. WangZ. APD3: the antimicrobial peptide database as a tool for research and education.Nucleic Acids Res.201644D1D1087D109310.1093/nar/gkv1278 26602694
     [Google Scholar]
  15. Sasaki-TanakaR. KandaT. YokooT. AbeH. HayashiK. SakamakiA. KamimuraH. TeraiS. Hepatitis A and E viruses are important agents of acute severe hepatitis in Asia: A narrative review.Pathogens202514545410.3390/pathogens14050454 40430774
     [Google Scholar]
  16. LodishH. BerkA. ZipurskyS.L. MatsudairaP. DNA Cloning with Plasmid Vectors.Molecular Cell. Biology, Fourth edi.New YorkW. H. Freeman2000
     [Google Scholar]
  17. FrogerA. HallJ.E. Transformation of plasmid DNA into E. coli using the heat shock method.J. Vis. Exp.2007625310.3791/253 18997900
     [Google Scholar]
  18. PalmerI. WingfieldP.T. Preparation and extraction of insoluble (Inclusion-body) proteins from Escherichia coli.Curr. Protoc. Protein Sci.201217060310.1002/0471140864.ps0603s70
     [Google Scholar]
  19. Cortés-RíosJ. ZárateA.M. FigueroaJ.D. Protein quantification by bicinchoninic acid (BCA) assay follows complex kinetics and can be performed at short incubation times.Anal. Biochem.202060811390410.1016/j.ab.2020.113904
     [Google Scholar]
  20. StringerK.L. TuranB. McCormickL. DurojaiyeM. NybladeL. KempfM-C. HHS Public Access.Physiol. Behav.2017176139148
     [Google Scholar]
  21. ModimolaM.S. GreenE. NjobehP. SenabeJ. FoucheG. McGawL. NkadimengS.M. MathibaK. MthombeniJ. Investigating the toxicity of compounds yielded by Staphylococci on vero cells.Toxins2022141071210.3390/toxins14100712 36287980
     [Google Scholar]
  22. LeiC. YangJ. HuJ. SunX. On the calculation of TCID50 for quantitation of virus infectivity.Virol. Sin.202136114114410.1007/s12250‑020‑00230‑5 32458296
     [Google Scholar]
  23. LaiY. HanT. ZhanS. JiangY. LiuX. LiG. Antiviral activity of isoimperatorin against influenza A virus in vitro and its inhibition of neuraminidase.Front. Pharmacol.202112April65782610.3389/fphar.2021.657826 33927632
     [Google Scholar]
  24. SinhaN.J. KloxinC.J. SavenJ.G. JensenG.V. KelmanZ. PochanD.J. Recombinant expression of computationally designed peptide-bundlemers in Escherichia coli.J. Biotechnol.2021330576010.1016/j.jbiotec.2021.03.004 33689866
     [Google Scholar]
  25. RydengårdV. ShannonO. LundqvistK. KacprzykL. ChalupkaA. OlssonA.K. MörgelinM. Jahnen-DechentW. MalmstenM. SchmidtchenA. Histidine-rich glycoprotein protects from systemic Candida infection.PLoS Pathog.200848e100011610.1371/journal.ppat.1000116 18797515
     [Google Scholar]
  26. NunesL.G.P. ReichertT. MachiniM.T. His-Rich peptides, Gly- and his-rich peptides: Functionally versatile compounds with potential multi-purpose applications.Int. J. Pept. Res. Ther.20212742945296310.1007/s10989‑021‑10302‑z
     [Google Scholar]
  27. WeberA. GibischM. TyrakowskiD. Cserjan-PuschmannM. Toca-HerreraJ.L. StriednerG. Recombinant peptide production softens Escherichia coli cells and increases their size during C-limited fed-batch cultivation.Int. J. Mol. Sci.2023243264110.3390/ijms24032641 36768962
     [Google Scholar]
  28. StoyanovA.V. RohlfingC.L. ConnollyS. RobertsM.L. NauserC.L. LittleR.R. Use of cation exchange chromatography for human C-peptide isotope dilution – Mass spectrometric assay.J. Chromatogr. A20111218519244924910.1016/j.chroma.2011.10.080 22098929
     [Google Scholar]
  29. NeshaniA. ZareH. AkbariE.M.R. KamaliK.R. SafdariH. KhalediA. GhazviniK. LL-37: Review of antimicrobial profile against sensitive and antibiotic-resistant human bacterial pathogens.Gene Rep.20191710051910.1016/j.genrep.2019.100519
     [Google Scholar]
  30. RidyardK.E. OverhageJ. The potential of human peptide ll-37 as an antimicrobial and anti-biofilm agent.Antibiotics202110665010.3390/antibiotics10060650 34072318
     [Google Scholar]
  31. NeghabiH.M. HajikhaniB. VaezjalaliM. SamadiK.H. KazemzadehA.R. GoudarziM. Antiviral and antibacterial peptides: Mechanisms of action.Heliyon20241022e4012110.1016/j.heliyon.2024.e40121 39748995
     [Google Scholar]
  32. GagatP. OstrówkaM. Duda-MadejA. MackiewiczP. Enhancing antimicrobial peptide activity through modifications of charge, hydrophobicity, and structure.Int. J. Mol. Sci.202425191082110.3390/ijms251910821 39409150
     [Google Scholar]
  33. ZhongQ. XiaoX. QiuY. XuZ. ChenC. ChongB. ZhaoX. HaiS. LiS. AnZ. DaiL. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.MedComm202343e26110.1002/mco2.261 37143582
     [Google Scholar]
/content/journals/ppl/10.2174/0109298665413796251002111415
Loading
Shepherin II Gene Synthesis and Peptide Characterization: E. coli Expression, Purification, and Antiviral Activity
PPL 32, 756 (2025); https://doi.org/10.2174/0109298665413796251002111415
/content/journals/ppl/10.2174/0109298665413796251002111415
/content/journals/ppl/10.2174/0109298665413796251002111415
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): antimicrobial peptide; antiviral activity; HAV; Histidine-glycine rich peptide; recombinant DNA technology; shepherin peptides

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test